A 63-year-old woman underwent a complex eight-hour surgery at Pune's Jupiter Hospital, where doctors removed a rare, benign ...

Duke neuroscientist Kafui Dzirasa wants nothing less than to reengineer the brain’s electrical patterns to treat anxiety, ...

Intra-Cellular has had success selling Caplyta, a brain-rebalancing drug that's approved to treat schizophrenia and bipolar ...

Acquisition includes CAPLYTA® (lumateperone), the first and only U.S. FDA-approved treatment for bipolar I and II depression as an adjunctive and ...

Meet Harvard-trained neuroscientist, Cape Cod writer Lisa Genova, ('Still Alice,') in East Sandwich as she explores bipolar ...

Researchers are pointing toward a potential biomarker in the ... Cannabis Disrupts Brain Activity in Young Adults Prone to Psychosis Nov. 20, 2024 — Young adults at risk of psychosis show ...

Light can also affect mood and mental health as the seasons change. During autumn and winter, symptoms such as low mood and ...

Already approved for smoking and treatment-resistant depression, brain stimulation is being tested for multiple addictions ...

A collaborative effort between Mount Sinai and Memorial Sloan Kettering Cancer Center has shed valuable light on how monoamine neurotransmitters such as serotonin, dopamine, and now histamine help ...

A collaborative effort has shed valuable light on how monoamine neurotransmitters such as serotonin, dopamine, and now histamine help regulate brain physiology and behavior through chemical bonding of ...

The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “Fulfilling the Promise of Noninvasive Brain Stimulation as a Precision Medicine Tool” on Tuesday, January 14, 2025, at 2:00 ...

A collaborative effort between Mount Sinai and Memorial Sloan Kettering Cancer Center has shed valuable light on how ...